News

Drug Development Is Slowing Down After Cuts at the FDA
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Experimental Drug Effectively Treats Alzheimer’s in Preclinical Study
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...
Prostate cancer drug now available to more patients with aggressive form of disease
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
F.D.A. Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...
Kennedy Accuses F.D.A. of Drug Industry Influence That Barred Alternative Remedies
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address ...
FDA reverses course on telework after layoffs and resignations threaten basic operations
The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...
FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
Pfizer ends development of weight-loss pill after patient's liver injury
Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...
Watch These Moderna Price Levels as Stock Sinks to 5-Year Low
Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and ...
Fox News10d
Prostate cancer drug now available to more patients with aggressive form of disease
A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease ... on March 28 that the U.S. Food and Drug Administration (FDA) has expanded approval ...
The Hill6d
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...